Piramal Pharma Limited Announces Consolidated Results for Q1FY24

/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), today announced its consolidated results for the first quarter (Q1) ended 30th June 2023....

Related Keywords

Hong Kong ,India ,United States ,Mumbai ,Maharashtra ,United Kingdom ,New York ,Singapore ,London ,City Of ,Grangemouth ,Falkirk ,Nandini Piramal ,Management Team ,Contract Development ,Manufacturing Organization ,Apotex Inc ,Facebook ,Carlyle Group ,Twitter ,Piramal Pharma Solutions ,Yapan Bio Private ,Accord Healthcare Inc ,Allergan India Private ,Piramal Pharma ,Piramal Pharma Ltd ,Abbvie Inc ,Piramal Pharma Limited ,Hospital Generic ,Consumer Healthcare ,Official Action Indicated ,Jeffrey Hampton ,Chief Operating Officer ,Piramal Critical Care ,Rights Issue ,Record Date ,Entitlement Ratio ,Inhalation Anesthesia ,India Consumer Healthcare ,Business Highlights ,Hospital Generics ,Accord Healthcare ,Lacto Calamine ,Pharma Limited ,Primary Number ,Eastern Time ,London Time ,Singapore Time ,Hong Kong Time ,Diamond Pass ,Allergan India Private Limited ,